ALDH1 Cancer Stem Cell Marker as a Prognostic Factor in Triple-Negative Breast Cancer

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Variable expression ALDH</td><td class="align_center">HR (IK 95%)</td><td class="align_center">HR change (%)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left"><i>Crude HR</i></td><td class="align_center">2.636 (1.168–5.950)</td><td class="align_left"> </td></tr><tr><td class="align_left" colspan="3"><hr/></td></tr><tr><td class="align_left" colspan="3"><i>Adjusted HR</i></td></tr><tr><td class="align_left">+ Stadium</td><td class="align_center">0.969 (0.373–2.157)</td><td class="align_center">63.24</td></tr><tr><td class="align_left">+ Chemotherapy</td><td class="align_center">0.982 (0.373–2.157)</td><td class="align_center">1.3</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Crude HR and adjusted HR with 95% IK for ALDH1 expression for mortality in the gradual addition of confounding variables.</div>

International Journal of Surgical Oncology

tab4

Table 4

Table 4: ALDH1 Cancer Stem Cell Marker as a Prognostic Factor in Triple-Negative Breast Cancer 